Skip to main content
Top
Published in: BMC Gastroenterology 1/2023

Open Access 01-12-2023 | Ulcerative Colitis | Research

Molecular analyses of ADAMTS-1, -4, -5, and IL-17 a cytokine relationship in patients with ulcerative colitis

Authors: Tahir Buran, Muhammet Burak Batır, Fethi Sırrı Çam, Elmas Kasap, Fatih Çöllü, Hamide Betül Gerik Çelebi, Mustafa Şahin

Published in: BMC Gastroenterology | Issue 1/2023

Login to get access

Abstract

Background

Ulcerative colitis (UC) is a chronic inflammatory bowel disease that develops due to the impaired immune response in genetically susceptible individuals, and its etiopathogenesis is not fully elucidated. IL-17 A is a cytokine that is produced by a type of immune cell called Th17 cells and is involved in the immune response and inflammation. On the other hand, ADAMTS-1, -4, and − 5 are enzymes that are involved in the breakdown of extracellular matrix proteins, including proteoglycans, which are important components of the intestinal wall. This study aimed to evaluate the relationship between interleukin 17 (IL-17 A) cytokine, which plays a role in the pathogenesis of ulcerative colitis, and the inflammation-controlled a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)-1, -4, and − 5 protein members.

Methods

Bowel tissue samples and blood serum from 51 patients with UC and 51 healthy controls were included in this study. mRNA expression levels of the ADAMTS-1, -4, -5, and IL-17 A were analyzed by RT-qPCR, and immunohistochemical analyses were performed to evaluate ADAMTS-1, -4, -5, and IL-17 A proteins in tissue samples. In addition, ELISA analysis determined serum levels of the ADAMTS-1, -4, -5, and IL-17 A.

Results

RT-qPCR results reveal that the expression of ADAMTS-1, -4, -5, and IL-17 A genes in the UC tissue samples were significantly high according to the control tissue samples. Also, ADAMTS-1, -4, -5, and IL-17 A proteins revealed enhanced expression pattern UC groups according to the control. Also, ADAMTS-1, -4, -5, and IL-17 A protein showed cytoplasmic localization patterns in both control and UC groups. The serum levels of ADAMTS-1,-5, and IL-17 A were significantly higher in UC samples than in the control group.

Conclusions

We observed a positive correlation between the ADAMTS-1, -5 and IL17A cytokine expression in UC samples. These results provide a new understanding of controlling crucial ADAMTS family protein members by IL-17 A cytokines with UC.
Literature
16.
go back to reference Miyamoto K, Ninomiya K, Sonoda T, Miyauchi Y, Muramatsu M, Nakamura T, Imai Y. Inhibition of IL-17A suppresses enhanced-tissue destruction in joints with CIA through promotion of the Treg cell response. Sci Rep. 2017;7:40066. Miyamoto K, Ninomiya K, Sonoda T, Miyauchi Y, Muramatsu M, Nakamura T, Imai Y. Inhibition of IL-17A suppresses enhanced-tissue destruction in joints with CIA through promotion of the Treg cell response. Sci Rep. 2017;7:40066.
20.
go back to reference Lopes N, Bergsland CH, Bjørnslett M, Pellinen T, Svindland A, Nesbakken A, Almeida R, Lothe RA, David L, Bruun J. Digital image analysis of multiplex fluorescence IHC in colorectal cancer recognizes the prognostic value of CDX2 and its negative correlation with SOX2. Laboratory investigation. J Tech Methods Pathol. 2020;100(1):120–34. https://doi.org/10.1038/s41374-019-0336-4.CrossRef Lopes N, Bergsland CH, Bjørnslett M, Pellinen T, Svindland A, Nesbakken A, Almeida R, Lothe RA, David L, Bruun J. Digital image analysis of multiplex fluorescence IHC in colorectal cancer recognizes the prognostic value of CDX2 and its negative correlation with SOX2. Laboratory investigation. J Tech Methods Pathol. 2020;100(1):120–34. https://​doi.​org/​10.​1038/​s41374-019-0336-4.CrossRef
23.
go back to reference Zhang X, Yu P, Wang Y, Jiang W, Shen F, Wang Y, Tu H, Yang X, Shi R, Zhang H. Genetic polymorphisms of interleukin 17A and interleukin 17F and their association with inflammatory bowel disease in a chinese Han population. Inflamm Research:Official J Eur Histamine Res Soc [et al]. 2013;62(8):743–50. https://doi.org/10.1007/s00011-013-0629-9.CrossRef Zhang X, Yu P, Wang Y, Jiang W, Shen F, Wang Y, Tu H, Yang X, Shi R, Zhang H. Genetic polymorphisms of interleukin 17A and interleukin 17F and their association with inflammatory bowel disease in a chinese Han population. Inflamm Research:Official J Eur Histamine Res Soc [et al]. 2013;62(8):743–50. https://​doi.​org/​10.​1007/​s00011-013-0629-9.CrossRef
25.
go back to reference Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Nakamura M, Yoshioka D, Arima Y, Okubo M, Hirata I, Nakano H. The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis. J Clin Immunol. 2008;28(1):44–9. https://doi.org/10.1007/s10875-007-9125-8.CrossRefPubMed Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Nakamura M, Yoshioka D, Arima Y, Okubo M, Hirata I, Nakano H. The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis. J Clin Immunol. 2008;28(1):44–9. https://​doi.​org/​10.​1007/​s10875-007-9125-8.CrossRefPubMed
29.
go back to reference Taylor RC, Webb Robertson BJ, Markillie LM, Serres MH, Linggi BE, Aldrich JT, Hill EA, Romine MF, Lipton MS, Wiley HS. Changes in translational efficiency is a dominant regulatory mechanism in the environmental response of bacteria. Integr Biol (Camb). 2013;5(11):1393–406. https://doi.org/10.1039/c3ib40120k.CrossRefPubMed Taylor RC, Webb Robertson BJ, Markillie LM, Serres MH, Linggi BE, Aldrich JT, Hill EA, Romine MF, Lipton MS, Wiley HS. Changes in translational efficiency is a dominant regulatory mechanism in the environmental response of bacteria. Integr Biol (Camb). 2013;5(11):1393–406. https://​doi.​org/​10.​1039/​c3ib40120k.CrossRefPubMed
34.
go back to reference Zhang H, Xia B, Li J, Zhao Q, Chen ZT, Zhou R, Wu J. Expression and clinical significance of IL-17 and IL-17 receptor in ulcerative colitis. J Huazhong Univ Sci Technol Med Sci = Hua Zhong ke ji da xue xue bao Yi xue Ying De wen ban = Huazhong keji daxue xuebao Yixue Yingdewen ban. 2016;36(1):37–40. https://doi.org/10.1007/s11596-016-1538-2.CrossRef Zhang H, Xia B, Li J, Zhao Q, Chen ZT, Zhou R, Wu J. Expression and clinical significance of IL-17 and IL-17 receptor in ulcerative colitis. J Huazhong Univ Sci Technol Med Sci = Hua Zhong ke ji da xue xue bao Yi xue Ying De wen ban = Huazhong keji daxue xuebao Yixue Yingdewen ban. 2016;36(1):37–40. https://​doi.​org/​10.​1007/​s11596-016-1538-2.CrossRef
Metadata
Title
Molecular analyses of ADAMTS-1, -4, -5, and IL-17 a cytokine relationship in patients with ulcerative colitis
Authors
Tahir Buran
Muhammet Burak Batır
Fethi Sırrı Çam
Elmas Kasap
Fatih Çöllü
Hamide Betül Gerik Çelebi
Mustafa Şahin
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2023
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-02985-z

Other articles of this Issue 1/2023

BMC Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.